St18 is a negative regulator of VEGF

July 14, 2020

Various pro-inflammatory cytokines and pathogen-associated molecular patterns such as lipopolysaccharide (LPS) are known to activate NF-kB. NF-kB is a master regulator of inflammation and induces pro-inflammatory cytokines. Although LPS-induced pro-inflammatory cytokiens are indispensable for host defense against pathogens, dysregulated production can lead to septic shock. Septic shock is the most common cause of death in intensive care unit. Pro-inflammatory cytokines in a systemic scale inflammatory response result in increased capillary permeability and low blood pressure. However, despite injection of anti-pro-inflammatory cytokine antibody into human septic shock, mortality rates remain high. Other than pro-inflammatory cytokines, macrophages can secrete vascular endothelial growth factor (VEGF) in response to LPS. VEGF was initially described as a stimulator of endothelial permeability. VEGF was subsequently reported to promote proliferation and survival of endothelial cells, and is now thought to be the pivotal regulator of angiogenesis and vascular leakage. Notably, VEGF exaggerates septic inflammation, and human serum VEGF level can be used as a predictor of septic prognosis. Thus, not only pro-inflammatory cytokines but also VEGF play critical roles for septic pathophysiology. Recently, Suppression of tumorigenicity 18 (St18) was discovered as a putative regulator of pro-inflammatory cytokine signaling. St18 is also reported as a candidate tumor suppressor in human breast tumors, because its expression is significantly down regulated in these cells compared to normal breast tissues. Conversely, St18 expression is up regulated in liver cancers, indicating an oncogenic function of this gene. Despite the pleiotropic functions of St18 in cancers, little is known about its functions in myeloid lineages. Maruyama and colleagues discovered that St18 is expressed in myeloid cells. Unexpectedly, mice lacking St18 in myeloid lineages exhibit increased retinal vasculature with enhanced serum VEGF concentrations, and pharmacological inhibition of VEGF signaling rescued the high mortality rate of septic shock. Mechanistically, St18 bound to Sp1 and attenuated its activity, leading to the suppression of Sp1 target gene VEGF. Thus, myeloid St18-mediated gene regulation may be a promising strategy for the development of therapeutics to control VEGF-associated disorders.

National Institutes of Natural Sciences

Related Septic Shock Articles from Brightsurf:

Early steroids improve outcomes in patients with septic shock
Some critically ill patients with septic shock need medications called vasopressors to correct dangerously low blood pressure.

Less aggressive treatment better for heart patients who go into shock
Less is sometimes more when treating heart patients who go into shock after a heart attack.

New testing system predicts septic shock outcomes
PME professor Savas Tay and his collaborators have developed a new, extremely sensitive method that can quantify bacteria, an antibiotic resistant gene, and immune molecule levels within sepsis patients, far more rapidly than current protocols.

Empty SV40 capsids increase survival of septic rats by eliciting numerous host signaling networks
The cover for issue 6 of Oncotarget features Figure 3, 'The effect of NCs treatments on routine lab results during disease and recovery progress,' by Ben-Nun-Shaul, et al.

At least 13% of wastewater treated by Southern Ontario septic systems ends up in streams
The presence of artificial sweeteners has revealed that at least 13 percent of septic system wastewater from rural Southern Ontario homes eventually makes its way into local streams.

Gene therapy success in chronic septic granulomatosis
American and British teams published yesterday in Nature Medicine the conclusive results of a gene therapy trial conducted in the United States and Great Britain in 9 patients with X-linked Chronic Septic Granulomatosis (X-CGD), a rare and severe immune dysfunction.

Vitamin C-B1-steroid combo linked to lower septic shock mortality in kids
Treating septic shock in children with a combination of intravenous vitamin C, vitamin B1 and hydrocortisone (a commonly used steroid) is associated with lower mortality, according to a study from Ann & Robert H.

VITAMINS trial report on vitamin C, hydrocortisone, thiamine for septic shock
In this randomized clinical trial of about 200 patients with septic shock, combination treatment with intravenous vitamin C, hydrocortisone and thiamine compared with intravenous hydrocortisone alone didn't significantly improve the amount of time patients were alive and free of medicines that raise blood pressure (vasopressors) over seven days.

Sphingotec's biomarker penKid® predicts septic acute kidney injury
Sphingotec reports study data demonstrating that its proprietary renal function biomarker penKid® (Proenkephalin) predicts acute kidney injury (AKI), multi-organ failure and mortality in sepsis patients presenting to the emergency department (ED).

Researchers create model to predict children likely to go into septic shock
Researchers at the University of Colorado Anschutz Medical Campus have developed a unique model allowing them to predict which children arriving in emergency departments are most likely to go into septic shock, a life-threatening condition.

Read More: Septic Shock News and Septic Shock Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to